Some consumers take tiny doses of Ozempic and other GLP-1 drugs or stretch out doses to cut costs and side effects.

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink).

Weight loss jabs could reduce the risk of up to 14 types of cancer, new research has found. Mounjaro, Ozempic and other ...

FROM sulphur burps to diarrhoea and nausea, there are many widely known Ozempic side effects – but there’s also a whole host of nasty long-term issues experts are only just uncovering.

Mounjaro, Ozempic and other fat-melting injections have ushered in a new era in the war on obesity, but have also been linked to other benefits, such as slashing heart attack risk.

GLP-1 drugs like Ozempic may lower the risk of obesity-related cancers, particularly colorectal cancer, among type 2 diabetes ...

Weight loss injections work by making you feel fuller and less hungry. There are plenty of weight loss medication options to ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Experts already know that losing weight reduces the risk of cancer, but now they think weight-loss jabs may have a role ...

First-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of ...

A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.